☆ 4.1 Meeting Abstract

Nitedanib plus Low-dose Cytarabine in non-intensive Patients with acute myeloid Leukemia: a randomized, placebo-controlled Phase 2 Study

ONCOLOGY RESEARCH AND TREATMENT (2022)

Journal

ONCOLOGY RESEARCH AND TREATMENT

Volume 45, Issue SUPPL 2, Pages 68-68

Publisher

KARGER

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.